MiNK Therapeutics, Inc. Stock Forecast
Red day on Thursday for MiNK Therapeutics, Inc. stock after losing 0.187%
(Updated on Mar 28, 2024)
The MiNK Therapeutics, Inc. stock price fell by -0.187% on the last day (Thursday, 28th Mar 2024) from $0.91 to $0.91. During the last trading day the stock fluctuated 3.00% from a day low at $0.90 to a day high of $0.93. The price has fallen in 5 of the last 10 days but is still up by 2.06% over the past 2 weeks. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 35 thousand shares were bought and sold for approximately $31.77 thousand.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -7.80% during the next 3 months and, with a 90% probability hold a price between $0.734 and $0.88 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
INKT Signals & Forecast
There are few to no technical positive signals at the moment. The MiNK Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.92. On a fall, the stock will find some support from the short-term average at $0.90. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, February 14, 2024, and so far it has fallen -9.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). MiNK Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for MiNK Therapeutics, Inc. stock
MiNK Therapeutics, Inc. finds support from accumulated volume at $0.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0271 between high and low, or 3.00%. For the last week, the stock has had daily average volatility of 3.89%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (INKT) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect MiNK Therapeutics, Inc. to open at $0.91, and during the day (based on 14 day Average True Range), to move between $0.85 and $0.97, which gives a possible trading interval of +/-$0.0597 (+/-6.58%) up or down from last closing price. If MiNK Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 13.15% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.91 (0.19%) than the support at $0.89 (2.01%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is MiNK Therapeutics, Inc. stock A Buy?
MiNK Therapeutics, Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -3.164 Sell Candidate Unchanged
Predicted Opening Price for MiNK Therapeutics, Inc. of Monday, April 1, 2024
Fair opening price April 1, 2024 | Current price |
---|---|
$0.91 ( 0.598%) | $0.91 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for INKT
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.94 | 3.58 % | |
R2 | 0.93 | 2.44 % | ||
R1 | 0.92 | 1.74 % | ||
Current price: | 0.91 | |||
Support | S1 | 0.90 | -0.542 % | |
S2 | 0.90 | -1.25 % | ||
S3 | 0.89 | -2.39 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 0.99 | 9.01 % | |
R2 | 0.93 | 2.39 % | ||
R1 | 0.91 | 0.187 % | ||
Current price | 0.91 | |||
Support | S1 | 0.89 | -2.01% | |
S2 | 0.89 | -2.47% | ||
S3 | 0.87 | -4.22% |
FAQ
Click here for our free guide on how to buy MiNK Therapeutics, Inc. Stock.